Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Blyth, Emily  [Clear All Filters]
Journal Article
Othman J, Greenwood M, Moore J, Larsen S, Watson A-M, Arthur C, Bhattacharyya A, Bilmon I, Blyth E, Bryant A, et al. Unrelated donor transplant recipients given Thymoglobuline have superior GRFS when compared to matched related donor recipients transplanted without ATG. Biol Blood Marrow Transplant. 2020.
Shnayder M, Nachshon A, Rozman B, Bernshtein B, Lavi M, Fein N, Poole E, Avdic S, Blyth E, Gottlieb D, et al. Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state. Elife. 2020;9.
Kliman D, Bilmon I, Kwan J, Blyth E, Micklethwaite K, Panicker S, Bhattacharyya A, Deren S, Antonenas V, Huang G, et al. Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single-centre case series. Intern Med J. 2018;48(8):988-991.
Bradstock K, Bilmon I, Kwan J, Blyth E, Micklethwaite K, Huang G, Deren S, Byth K, Gottlieb D. Influence of Stem Cell Source on Outcomes of Allogeneic Reduced Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors. Biol Blood Marrow Transplant. 2015.
Ma CKK, Clancy L, Deo S, Blyth E, Micklethwaite KP, Gottlieb DJ. Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy. Cytotherapy. 2016.
Withers B, Clancy L, Burgess J, Simms R, Brown R, Micklethwaite K, Blyth E, Gottlieb D. Establishment and operation of a third party virus-specific T-cell bank within an allogeneic stem cell transplant program. Biol Blood Marrow Transplant. 2018.
Blyth E, Withers B, Clancy L, Gottlieb D. CMV-specific immune reconstitution following allogeneic stem cell transplantation. Virulence. 2016:1-14.
Ma CKK, Blyth E, Clancy L, Simms R, Burgess J, Brown R, Deo S, Micklethwaite KP, Gottlieb DJ. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2015;17(10):1406-1420.